Loading...
Keywords
Last Name
Institution

Jennifer Schuster

Concepts (262)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiratory Tract Infections
11
2021
57
3.780
Why?
Enterovirus Infections
9
2021
29
3.180
Why?
Enterovirus D, Human
9
2021
21
3.130
Why?
Paramyxoviridae Infections
8
2016
10
2.470
Why?
Humans
54
2022
5931
2.380
Why?
Hematopoietic Stem Cell Transplantation
3
2020
43
2.350
Why?
Metapneumovirus
8
2016
9
2.310
Why?
Child, Preschool
29
2022
1492
2.150
Why?
Child
36
2022
2792
2.140
Why?
Disease Outbreaks
9
2021
23
1.950
Why?
Hospitalization
16
2022
169
1.940
Why?
Antibodies, Viral
6
2022
29
1.690
Why?
Rhinovirus
2
2020
6
1.590
Why?
Virus Diseases
2
2020
12
1.550
Why?
United States
21
2022
624
1.550
Why?
Female
27
2022
3348
1.350
Why?
Adolescent
25
2022
1960
1.350
Why?
Infant
21
2022
1388
1.270
Why?
Male
25
2022
3276
1.250
Why?
Mucocutaneous Lymph Node Syndrome
3
2020
7
1.130
Why?
Antibodies, Neutralizing
5
2021
29
0.980
Why?
Systemic Inflammatory Response Syndrome
5
2022
10
0.970
Why?
Communicable Diseases
2
2022
5
0.960
Why?
Vulnerable Populations
1
2022
5
0.950
Why?
Touch
1
2021
4
0.940
Why?
Spike Glycoprotein, Coronavirus
2
2022
19
0.940
Why?
School Health Services
1
2022
10
0.940
Why?
Respiratory System
1
2021
4
0.940
Why?
Immunization Schedule
2
2017
7
0.860
Why?
Gastroenteritis
1
2020
20
0.850
Why?
Asymptomatic Infections
1
2020
4
0.840
Why?
Pandemics
6
2022
49
0.840
Why?
Vaccination
4
2022
34
0.800
Why?
Hematologic Diseases
1
2018
4
0.760
Why?
Immunologic Deficiency Syndromes
1
2018
9
0.760
Why?
Pneumonia, Viral
2
2020
16
0.740
Why?
Prospective Studies
8
2022
470
0.730
Why?
Picornaviridae Infections
1
2018
18
0.730
Why?
Viruses
1
2018
2
0.730
Why?
Communicable Diseases, Emerging
1
2018
3
0.730
Why?
Communicable Disease Control
1
2018
7
0.720
Why?
Hyponatremia
1
2017
2
0.710
Why?
Critical Care
3
2021
13
0.700
Why?
Vaccines
1
2017
13
0.680
Why?
Neoplasms
1
2018
93
0.660
Why?
Public Health Practice
1
2016
1
0.660
Why?
Immunization Programs
1
2016
6
0.660
Why?
Respiratory Syncytial Virus Infections
4
2020
37
0.660
Why?
Infectious Disease Medicine
2
2022
2
0.640
Why?
Respiratory Syncytial Virus, Human
2
2016
18
0.580
Why?
Specialization
1
2014
8
0.580
Why?
Antibodies, Monoclonal, Humanized
1
2014
29
0.550
Why?
Hospitals, Pediatric
6
2022
183
0.540
Why?
Meningitis, Fungal
1
2013
1
0.530
Why?
Histoplasma
1
2013
3
0.530
Why?
Histoplasmosis
1
2013
3
0.530
Why?
Retrospective Studies
7
2022
1148
0.520
Why?
Treatment Outcome
5
2021
618
0.490
Why?
Pediatrics
1
2014
192
0.470
Why?
Population Surveillance
2
2021
15
0.460
Why?
Adult
4
2021
1096
0.430
Why?
Immunoglobulins, Intravenous
2
2021
7
0.420
Why?
Vaccines, Synthetic
4
2022
4
0.420
Why?
Longitudinal Studies
2
2020
123
0.410
Why?
Prevalence
2
2020
138
0.410
Why?
Case-Control Studies
5
2022
124
0.410
Why?
Fever
3
2019
33
0.400
Why?
Risk Factors
3
2015
403
0.390
Why?
Coronavirus Infections
2
2020
15
0.390
Why?
Influenza Vaccines
2
2020
12
0.390
Why?
Influenza, Human
2
2020
34
0.380
Why?
Infant, Newborn
7
2022
877
0.350
Why?
Severity of Illness Index
2
2020
145
0.340
Why?
Advisory Committees
2
2017
9
0.340
Why?
Animals
5
2016
869
0.320
Why?
Critical Illness
2
2022
20
0.300
Why?
Intensive Care Units
2
2022
17
0.300
Why?
Pregnancy Complications, Infectious
2
2022
27
0.300
Why?
Schools
2
2022
33
0.290
Why?
Public Health Surveillance
2
2021
4
0.280
Why?
Disease Models, Animal
2
2014
79
0.280
Why?
Echocardiography
3
2020
58
0.270
Why?
Length of Stay
3
2020
225
0.270
Why?
Immunoglobulin G
2
2021
34
0.260
Why?
Coinfection
1
2022
2
0.250
Why?
Regression Analysis
2
2021
59
0.240
Why?
Age Factors
3
2021
225
0.240
Why?
Neutralization Tests
3
2022
6
0.240
Why?
Immunity, Maternally-Acquired
1
2022
1
0.240
Why?
Academic Medical Centers
1
2022
10
0.240
Why?
Disabled Children
1
2022
7
0.240
Why?
Community-Institutional Relations
1
2022
9
0.240
Why?
Minority Groups
1
2022
17
0.240
Why?
Child, Hospitalized
1
2022
29
0.240
Why?
Education, Distance
1
2022
4
0.240
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2020
87
0.240
Why?
Urban Population
1
2022
40
0.230
Why?
Molecular Diagnostic Techniques
2
2021
36
0.230
Why?
Ventricular Dysfunction, Left
1
2021
14
0.230
Why?
Vaccine Potency
1
2021
7
0.230
Why?
Follow-Up Studies
2
2021
314
0.220
Why?
Nervous System Diseases
1
2021
16
0.220
Why?
Glucocorticoids
1
2021
35
0.220
Why?
Influenza A Virus, H3N2 Subtype
1
2020
4
0.220
Why?
Influenza A Virus, H1N1 Subtype
1
2020
5
0.220
Why?
Immunocompromised Host
1
2020
9
0.220
Why?
Tomography, X-Ray Computed
1
2021
118
0.210
Why?
Mouth
1
2020
3
0.210
Why?
Acute Disease
1
2020
65
0.210
Why?
DNA, Viral
1
2020
13
0.210
Why?
Myelitis
1
2020
1
0.210
Why?
Monitoring, Physiologic
1
2020
23
0.210
Why?
Neuromuscular Diseases
1
2020
3
0.210
Why?
Central Nervous System Viral Diseases
1
2020
3
0.210
Why?
Postoperative Care
1
2020
29
0.210
Why?
Seasons
2
2020
15
0.200
Why?
Prognosis
1
2020
180
0.200
Why?
Risk Assessment
1
2020
138
0.200
Why?
Biomarkers
2
2021
120
0.200
Why?
Infliximab
1
2019
7
0.200
Why?
Cough
2
2015
7
0.190
Why?
Diagnosis, Differential
2
2021
79
0.190
Why?
CD8-Positive T-Lymphocytes
2
2015
7
0.190
Why?
Metabolic Diseases
1
2018
13
0.190
Why?
Virus Replication
2
2015
7
0.190
Why?
Reassortant Viruses
1
2018
1
0.180
Why?
Orthomyxoviridae
1
2018
2
0.180
Why?
Organoplatinum Compounds
1
2017
1
0.180
Why?
Sodium
1
2017
6
0.180
Why?
Hypotension
1
2017
4
0.180
Why?
Patient Acuity
3
2022
8
0.170
Why?
Yellow Fever Vaccine
1
2017
1
0.170
Why?
Meningococcal Vaccines
1
2017
2
0.170
Why?
Respiratory Syncytial Virus Vaccines
1
2017
3
0.170
Why?
Herpes Zoster Vaccine
1
2017
2
0.170
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2017
3
0.170
Why?
Magnetic Resonance Imaging
2
2020
83
0.170
Why?
Hepatitis B Vaccines
1
2017
2
0.170
Why?
Papillomavirus Vaccines
1
2017
7
0.170
Why?
Pneumococcal Vaccines
1
2017
14
0.170
Why?
Practice Guidelines as Topic
1
2017
98
0.170
Why?
Pregnancy
3
2022
251
0.170
Why?
Mutation
1
2018
198
0.170
Why?
Societies, Medical
1
2016
43
0.160
Why?
Replicon
1
2016
1
0.160
Why?
Viral Vaccines
1
2016
3
0.160
Why?
Recombination, Genetic
1
2015
4
0.160
Why?
Virus Internalization
1
2015
1
0.160
Why?
Jordan
1
2015
1
0.160
Why?
Respiratory Mucosa
1
2015
5
0.160
Why?
Tertiary Care Centers
1
2015
8
0.150
Why?
Vaccines, Virus-Like Particle
1
2015
1
0.150
Why?
Disease Management
1
2015
38
0.150
Why?
Interferon Type I
1
2015
2
0.150
Why?
Asthma
2
2015
135
0.150
Why?
Community Networks
1
2014
3
0.150
Why?
Cross Protection
1
2014
1
0.140
Why?
Seroepidemiologic Studies
1
2014
3
0.140
Why?
Emergency Medical Services
1
2014
18
0.140
Why?
Disease Transmission, Infectious
1
2014
11
0.140
Why?
Physicians
1
2014
22
0.140
Why?
Antibodies, Monoclonal
1
2014
23
0.140
Why?
Mice, Inbred DBA
1
2014
3
0.140
Why?
Chemoprevention
1
2014
4
0.140
Why?
Mice, Inbred BALB C
1
2014
29
0.140
Why?
Genetic Variation
1
2015
143
0.140
Why?
Lung
1
2015
93
0.140
Why?
Immunotherapy
1
2014
14
0.140
Why?
Gene Expression Regulation
1
2015
139
0.140
Why?
Cytopathogenic Effect, Viral
1
2013
2
0.140
Why?
Virulence
1
2013
6
0.140
Why?
Opportunistic Infections
1
2013
7
0.140
Why?
Signal Transduction
1
2015
147
0.130
Why?
Bronchiolitis
1
2013
11
0.130
Why?
Predictive Value of Tests
1
2013
101
0.130
Why?
Disease Progression
1
2013
92
0.130
Why?
Radiography
1
2013
40
0.130
Why?
Polymerase Chain Reaction
1
2013
98
0.130
Why?
Recurrence
1
2013
104
0.130
Why?
Chronic Disease
1
2013
101
0.130
Why?
Young Adult
3
2021
582
0.130
Why?
Brain
1
2013
88
0.120
Why?
Cross-Sectional Studies
1
2013
275
0.120
Why?
Viral Fusion Proteins
3
2016
3
0.120
Why?
Cohort Studies
2
2022
259
0.110
Why?
Flow Cytometry
2
2015
28
0.080
Why?
Mice, Inbred C57BL
2
2015
127
0.070
Why?
Mice
2
2015
432
0.070
Why?
Policy
1
2022
3
0.060
Why?
Viral Envelope Proteins
1
2022
3
0.060
Why?
Membrane Glycoproteins
1
2022
11
0.060
Why?
Immunization, Passive
1
2022
1
0.060
Why?
Life Support Care
1
2022
1
0.060
Why?
Immunization, Secondary
1
2022
2
0.060
Why?
Mothers
1
2022
34
0.060
Why?
Saliva
1
2021
9
0.060
Why?
Infectious Disease Transmission, Vertical
1
2022
25
0.060
Why?
Specimen Handling
1
2021
17
0.060
Why?
Nasopharynx
1
2021
23
0.060
Why?
Immunomodulation
1
2021
1
0.060
Why?
Propensity Score
1
2021
10
0.060
Why?
Shock
1
2021
4
0.060
Why?
Drug Therapy, Combination
1
2021
43
0.060
Why?
Combined Modality Therapy
1
2021
51
0.060
Why?
Intensive Care Units, Pediatric
1
2021
7
0.060
Why?
Stroke Volume
1
2021
14
0.060
Why?
Comorbidity
1
2021
66
0.060
Why?
Logistic Models
1
2021
95
0.060
Why?
RNA, Messenger
1
2021
178
0.060
Why?
Clinical Laboratory Techniques
1
2020
9
0.050
Why?
Hospital Costs
1
2020
27
0.050
Why?
Patient Discharge
1
2021
56
0.050
Why?
International Classification of Diseases
1
2020
8
0.050
Why?
Drug Resistance
1
2019
6
0.050
Why?
Inflammation Mediators
1
2019
8
0.050
Why?
Comparative Effectiveness Research
1
2019
6
0.050
Why?
Time Factors
1
2020
277
0.050
Why?
Cross-Over Studies
1
2019
31
0.050
Why?
Emergency Service, Hospital
1
2020
139
0.050
Why?
Practice Patterns, Nurses'
1
2017
5
0.040
Why?
Algorithms
1
2017
95
0.040
Why?
Practice Patterns, Physicians'
1
2017
86
0.040
Why?
Alphavirus
1
2016
1
0.040
Why?
Encephalitis Virus, Venezuelan Equine
1
2016
1
0.040
Why?
Nose
1
2016
7
0.040
Why?
Bronchoalveolar Lavage Fluid
1
2016
16
0.040
Why?
Sequence Homology
1
2015
2
0.040
Why?
Evolution, Molecular
1
2015
3
0.040
Why?
Endosomes
1
2015
1
0.040
Why?
Bronchi
1
2015
2
0.040
Why?
Microscopy, Confocal
1
2015
3
0.040
Why?
Genome, Viral
1
2015
4
0.040
Why?
Molecular Epidemiology
1
2015
6
0.040
Why?
Transfection
1
2015
31
0.040
Why?
Phylogeny
1
2015
18
0.040
Why?
RNA, Small Interfering
1
2015
15
0.040
Why?
Cluster Analysis
1
2015
30
0.040
Why?
Illinois
1
2015
5
0.040
Why?
Dyspnea
1
2015
5
0.040
Why?
Colorado
1
2015
9
0.040
Why?
Respiratory Sounds
1
2015
9
0.040
Why?
Molecular Sequence Data
1
2015
117
0.040
Why?
Respiration, Artificial
1
2015
31
0.040
Why?
Cell Line
1
2015
104
0.040
Why?
Lymphocyte Depletion
1
2015
1
0.040
Why?
Viral Matrix Proteins
1
2015
1
0.040
Why?
Programmed Cell Death 1 Receptor
1
2015
2
0.040
Why?
Macaca mulatta
1
2015
22
0.040
Why?
HEK293 Cells
1
2015
31
0.040
Why?
Aged, 80 and over
1
2015
116
0.040
Why?
Missouri
1
2015
90
0.040
Why?
Mice, Transgenic
1
2015
50
0.040
Why?
Sequence Analysis, DNA
1
2015
102
0.040
Why?
Antigen-Presenting Cells
1
2015
1
0.040
Why?
Receptors, Virus
1
2015
2
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2015
80
0.040
Why?
Analysis of Variance
1
2015
28
0.040
Why?
Oximetry
1
2015
9
0.040
Why?
Real-Time Polymerase Chain Reaction
1
2015
33
0.040
Why?
Mice, Knockout
1
2015
99
0.040
Why?
Aged
1
2015
306
0.040
Why?
Middle Aged
1
2015
567
0.030
Why?
Schuster's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_